100 related articles for article (PubMed ID: 1680554)
1. On the pharmacokinetics of 2-chloro-2'-deoxyadenosine in humans.
Liliemark J; Juliusson G
Cancer Res; 1991 Oct; 51(20):5570-2. PubMed ID: 1680554
[TBL] [Abstract][Full Text] [Related]
2. Determination of 2-chloro-2'-deoxyadenosine in human plasma.
Liliemark J; Pettersson B; Juliusson G
Biomed Chromatogr; 1991 Nov; 5(6):262-4. PubMed ID: 1684727
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
Kearns CM; Blakley RL; Santana VM; Crom WR
Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
[TBL] [Abstract][Full Text] [Related]
4. Cellular pharmacokinetics of 2-chloro-2'-deoxyadenosine nucleotides: comparison of intermittent and continuous intravenous infusion and subcutaneous and oral administration in leukemia patients.
Liliemark J; Juliusson G
Clin Cancer Res; 1995 Apr; 1(4):385-90. PubMed ID: 9815995
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion.
Sonderegger T; Betticher DC; Cerny T; Lauterburg BH
Cancer Chemother Pharmacol; 2000; 46(1):40-2. PubMed ID: 10912576
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia.
Lindemalm S; Liliemark J; Juliusson G; Larsson R; Albertioni F
Cancer Lett; 2004 Jul; 210(2):171-7. PubMed ID: 15183532
[TBL] [Abstract][Full Text] [Related]
7. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
9. Determination of 2-bromo and 2-chloro derivatives of 2'-deoxyadenosine in human blood serum by high performance liquid chromatography.
Gajewska M; Pawiński T; Dzierzgowska-Szmidt A; Grieb P; Ryba M
Acta Pol Pharm; 1994; 51(2):109-14. PubMed ID: 7863784
[TBL] [Abstract][Full Text] [Related]
10. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
Santana VM; Mirro J; Harwood FC; Cherrie J; Schell M; Kalwinsky D; Blakley RL
J Clin Oncol; 1991 Mar; 9(3):416-22. PubMed ID: 1671875
[TBL] [Abstract][Full Text] [Related]
11. A method for determining 4-aminopyridine in plasma: pharmacokinetics in anaesthetized guinea pigs after intravenous administration.
Capacio BR; Byers CE; Matthews RL; Chang FC
Biomed Chromatogr; 1996; 10(3):111-6. PubMed ID: 8792860
[TBL] [Abstract][Full Text] [Related]
12. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
13. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
[TBL] [Abstract][Full Text] [Related]
14. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
Gandhi V; Chen W; Ayres M; Rhie JK; Madden TL; Newman RA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):85-94. PubMed ID: 12172971
[TBL] [Abstract][Full Text] [Related]
15. 2-CdA in the treatment of hairy cell leukaemia.
Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hairy cell leukemia patients with 2-chloro-2'-deoxyadenosine (2-CdA).
Komarnicki M; Kaźmierczak M; Hansz J
Arch Immunol Ther Exp (Warsz); 1994; 42(1):31-2. PubMed ID: 7503630
[TBL] [Abstract][Full Text] [Related]
17. 2-Chloro-2'-deoxyadenosine--clinical, biochemical and pharmacokinetic considerations.
Liliemark J; Juliusson G
Arch Immunol Ther Exp (Warsz); 1994; 42(1):7-10. PubMed ID: 7503639
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.
Ueda T; Nakamura T; Ando S; Kagawa D; Sasada M; Uchino H; Johno I; Akiyama Y
Cancer Res; 1983 Jul; 43(7):3412-6. PubMed ID: 6850647
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
